Corrigendum to: Decline of miR-124 in myeloid cells promotes regulatory T-cell development in hepatitis C virus infection (Immunology, (2017), 150, 2, (213-220), 10.1111/imm.12680);Decline of miR-124 in myeloid cells promotes regulatory T-cell development in hepatitis C virus infection

Immunology

Volumn 150, Issue 2, 2017, Pages 213-220

  Ren, Jun P ^a   Wang, Lin ^a,b   Zhao, Juan ^a   Wang, Ling ^a   Ning, Shun B ^a   El Gazzar, Mohamed ^a   Moorman, Jonathan P ^a,c   Yao, Zhi Q ^a,c  

^a East Tennessee State University   (United States)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c James H Quillen VA Medical Center   (United States)

Author keywords

hepatitis C virus; microRNA 124; myeloid derived suppressor cells; regulatory T cells; signal transducer and activator of transcription 3

Indexed keywords

INTERLEUKIN 10; MICRORNA 124; STAT3 PROTEIN; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; MICRORNA; MIRN124 MICRORNA, HUMAN; SMALL INTERFERING RNA; STAT3 PROTEIN, HUMAN;

ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL EXPANSION; CELL MATURATION; DOWN REGULATION; GENE EXPRESSION; HEPATITIS C; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; UPREGULATION; BIOLOGY; CELL CULTURE; CHRONIC HEPATITIS C; GENETICS; HEPACIVIRUS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MYELOID-DERIVED SUPPRESSOR CELL; PHYSIOLOGY; VIROLOGY;

CELLS, CULTURED; COMPUTATIONAL BIOLOGY; DOWN-REGULATION; FORKHEAD TRANSCRIPTION FACTORS; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERLEUKIN-10; LYMPHOCYTE ACTIVATION; MICRORNAS; MYELOID-DERIVED SUPPRESSOR CELLS; RNA, SMALL INTERFERING; STAT3 TRANSCRIPTION FACTOR; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA;

EID: 85000401575     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/imm.13491     Document Type: Erratum

References (45)

1. Park SH, Rehermann B. Immune responses to HCV and other hepatitis viruses. Immunity 2014; 40:13–24.
2. Rosen HR. Emerging concepts in immunity to hepatitis C virus infection. J Clin Invest 2013; 123:4121–30.
3. Ostrand-Rosenberg S, Sinha P. Myeloid-derived suppressor cells: linking inflammation and cancer. J Immunol 2009; 182:4499–506.
4. Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 2009; 9:162–74.
5. Dai J, El Gazzar M, Li GY, Moorman JP, Yao ZQ. Myeloid-derived suppressor cells: paradoxical roles in infection and immunity. J Innate Immun 2014; 7:116–26.
6. Corzo CA, Cotter MJ, Cheng P, Cheng F, Kusmartsev S, Sotomayor E et al. Mechanism regulating reactive oxygen species in tumor-induced myeloid-derived suppressor cells. J Immunol 2009; 182:5693–701.
7. hi and overexpress CD80, CD83, and DC-sign. Cancer Res 2010; 70:4335–45.
8. Filipazzi P, Valenti R, Huber V et al. Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor-based antitumor vaccine. J Clin Oncol 2007; 25:2546–53.
9. + T cells. Gastroenterology 2008; 135:234–43.
10. Vasquez-Dunddel D1, Pan F, Zeng Q et al. STAT3 regulates arginase-I in myeloid-derived suppressor cells from cancer patients. J Clin Invest 2013; 123:1580–9.
11. Chen K, Rajewsky N. The evolution of gene regulation by transcription factors and microRNAs. Nat Rev Genet 2007; 8:93–103.
12. Lee CH, Kim JH, Lee SW. The role of microRNAs in hepatitis C virus replication and related liver diseases. J Microbiol 2014; 52:445–51.
13. Zhang YL, Wei W, Cheng N et al. Hepatitis C virus-induced up-regulation of microRNA-155 promotes hepatocarcinogenesis by activating Wnt signaling. Hepatology 2012; 56:1631–40.
14. Cheng YQ, Ren JP, Zhao J et al. MicroRNA-155 regulates interferon-γ production in natural killer cells via Tim-3 signalling in chronic hepatitis C virus infection. Immunology 2015; 145:485–97.
15. + T-cell responses through overexpression of DUSP6. Hepatology 2015; 61:1163–73.
16. Ren JP, Ying RS, Cheng YQ et al. HCV-induced miR146a controls SOCS1/STAT3 and cytokine expression in monocytes to promote regulatory T cell development. J Viral Hepatitis 2016; 23:755–66.
17. Mukheriee A, Shrivastava S, Bhania CJ, Ray R, Ray RB. Transcriptional suppression of miR-181c by hepatitis C virus enhances homeobox A1 expression. J Virol 2014; 88:7929–40.
18. Estrabaud E, Lapalus M, Broet P et al. Reduction of microRNA 122 expression in IFNL3 CT/TT carriers and during progression of fibrosis in patients with chronic hepatitis C. J Virol 2014; 88:6394–402.
19. Ren JP, Zhao J, Dai J et al. Hepatitis C virus-induced myeloid-derived suppressor cells regulate T cell differentiation and function via the STAT3 pathway. Immunology 2016; 148:377–86.
20. + individuals. AIDS 2016; 30:1521–31.
21. Huang A, Zhang B, Yan WW et al. Myeloid-derived suppressor cells regulate immune response in patients with chronic hepatitis B virus infection through PD-1-induced IL-10. J Immunol 2014; 193:5461–9.
22. Vollbrechi T, Striner R, Tufman A et al. Chronic progressive HIV-1 infection is associated with elevated levels of myeloid-derived suppressor cells. AIDS 2012; 26:F31–7.
23. Qin A, Cai W, Pan T et al. Expansion of monocytic myeloid-derived suppressor cells dampens T cell function in HIV-1-seropositive individuals. J Virol 2013; 87:1477–90.
24. Garg A, Spector SA. HIV type 1 gp120-induced expansion of myeloid derived suppressor cells is dependent on interleukin 6 and suppresses immunity. J Infect Dis 2014; 209:441–51.
25. low/neg monocytes functionally similar to myeloid-derived suppressor cells during SIV and HIV infection. J Leukoc Biol 2012; 91:803–16.
26. Tacke RS, Lee HC, Goh C et al. Myeloid suppressor cells induced by hepatitis C virus suppress T-cell responses through the production of reactive oxygen species. Hepatology 2012; 55:343–53.
27. + T cells in chronic hepatitis C patients. Mol Cells 2014; 37:66–73.
28. Cai W, Qin A, Guo P et al. Clinical significance and functional studies of myeloid-derived suppressor cells in chronic hepatitis C patients. J Clin Immunol 2013; 33:798–808.
29. Norris BA, Uebelhoer LS, Nakaya HI, Price AA, Grakoui A, Pulendran B. Chronic but not acute virus infection induces sustained expansion of myeloid suppressor cell numbers that inhibit viral-specific T cell immunity. Immunity 2013; 38:309–21.
30. El Gazzar M. microRNAs as potential regulators of myeloid-derived suppressor cell expansion. Innate Immun 2014; 20:227–38.
31. Saleem SJ, Conrad DH. Hematopoietic cytokine-induced transcriptional regulation and Notch signaling as modulators of MDSC expansion. Int Immunopharmacol 2011; 11:808–15.
32. Koukos G, Polytarchou C, Kaplan JL et al. MicroRNA-124 regulates STAT3 expression and is down-regulated in colon tissues of pediatric patients with ulcerative colitis. Gastroenterology 2013; 145:842–52.
33. Zhang J, Lu Y, Yue X et al. MiR-124 suppresses growth of human colorectal cancer by inhibiting STAT3. PLoS One 2013; 8:e70300.
34. Han YC, Park CY, Bhagat G et al. microRNA-29a induces aberrant self-renewal capacity in hematopoietic progenitors, biased myeloid development, and acute myeloid leukemia. J Exp Med 2010; 207:475–89.
35. Rozovski U, Calin GA, Setoyama T et al. Signal transducer and activator of transcription (STAT)-3 regulates microRNA gene expression in chronic lymphocytic leukemia cells. Mol Cancer 2013; 12:50.
36. Siomi H, Siomi MC. Posttranscriptional regulation of microRNA biogenesis in animals. Mol Cell 2010; 38:1018–25.
37. Thomas MF, Abdul-Wajid S, Panduro M et al. Eri1 regulates microRNA homeostasis and mouse lymphocyte development and antiviral function. Blood 2012; 120:130–42.
38. Song H, Wang RX, Wang SM, Lin JY. A low-molecular-weight compound discovered through virtual database screening inhibits Stat3 function in breast cancer cells. PNAS 2005; 102:4700–5.
39. Tacke RS, Tosello-Trampont A, Nguyen V, Mullins DW, Hahn SH. Extracellular hepatitis C virus core protein activates STAT3 in human monocytes/macrophages/dendritic cells via an IL-6 autocrine pathway. J Biol Chem 2011; 286:10847–55.
40. Korrylewski M, Kujawski M, Wang T et al. Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity. Nat Med 2005; 11:1314–21.
41. O'Connell RM, Zhao JL, Rao DS. MicroRNA function in myeloid biology. Blood 2011; 118:2960–9.
42. Boldin MP, Taganov KD, Rao DS et al. miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice. J Exp Med 2011; 208:1189–201.
43. Johnnidis JB, Harris MH, Wheeler RT et al. Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. Nature 2008; 451:1125–9.
44. Fontana L, Pelosi E, Greco P et al. MicroRNAs 17-5p-20a-106a control monocytopoiesis through AML1 targeting and M-CSF receptor upregulation. Nat Cell Biol 2007; 9:775–87.
45. Zeng B, Li Z, Chen R et al. Epigenetic regulation of miR-124 by hepatitis C virus core protein promotes migration and invasion of intrahepatic cholangiocarcinoma cells by targeting SMYD3. FEBS Lett 2012; 586:3271–8.